In lung cancer cells, interventions that sustain mitochondrial fusion (whether caused by inhibiting Drp1 or augmentation of Mfn2) reduce cell proliferation and increase spontaneous apoptosis [133]. This evidence concerns the gene MFN2 and lung cancer.